Main MFIII HP Presentation

Quick Links



Clinical Trials & Research Case Studies

MFIII Human Placenta Injections have been researched and developed based on years of scientific data. Cell Therapy has been proven to be remarkably dynamic in treating and relieving a wide range of ailments and conditions, both related to aging and not. MFIII HP230 is based on cellular rejuvenation and improvement and has the potential to aid in the treatment and rejuvenation of a number of different conditions, as it contains amino acids, vitamins and hundreds of enzymes.


Boosts Collagen Production

Collagen is a type of protein. Fibrous in nature, it connects and supports other bodily tissues, such as skin, bones, tendons, muscles, cartilage and internal organs. There are more than 25 types of collagens that naturally occur in the body. Some people refer to collagen as the glue that holds the body together. Without it, the body would, quite literally, fall apart. Human Placenta can increase and accelerate collagen synthesis, vastly improving skin conditions. It works with keratin to provide the skin with strength, flexibility, and resilience. As people age, collagen degradation occurs, leading to wrinkles. As such, it is an important substance for those looking for ways to fight the visible effects of aging on the skin.






Increases Phagocytic Cells

Phagocytes are the white blood cells that protect the body by ingesting (phagocytosing) harmful foreign particles, bacteria and dead or dying cells. They are essential for fighting infections and for subsequent immunity. Phagocytes are important throughout the animal kingdom, and are highly-developed invertebrates. One liter of human blood contains about six billion phagocytes. During an infection, chemical signals attract phagocytes to places where the pathogen has invaded the body. When bacteria touch a phagocyte, they bind to the receptors on the phagocyte's surface and are then consumed.


Reduces Pain

Oral sub-mucous fibrosis manifests as stiffness of oral mucosa, a burning sensation and an inability to eat. Katharia et al. utilised placenta extract to achieve stunning results. Placenta extract was administered parenterally and effects were monitored in reducing the severity of the disease. There was significant improvement in mouth opening, color of oral mucosa, reduction of burning sensation, and reduction of fibrous bands.


Treatment of Gastric or Duodenal Ulcers

The parenteral administration of placenta for the treatment of gastric and duodenal ulcers was investigated in Japan and conducted by Nakazawa et al. Using endoscopic and X-ray technology as diagnostic tools, they found 95% of patients in the group treated with placenta extract were responsive to treatment. Bianchini et al. found similar results.


Eases Inflammation

Sur et al. showed the anti-inflammatory effects of human placental extract by inducing inflammation in the hind paws of rats. They found a significant inhibition of paw oedema in the group treated with human placental extract.


Defies Malignancy

Using fast-growing and undifferentiated rat tumor cells, Carbo et al. demonstrated the inhibitory action of pregnant rat plasma. Tumor cells from untreated rats were seeded in culture dishes, with or without the presence of pregnant rat plasma. In comparison with cells that were grown in the presence of virgin rat plasma, there was a 34% decrease in growth in the culture dishes with pregnant rat plasma. Pregnant rat plasma induced apoptosis in tumor cells.


Inhibits Bacterial and Fungal Growth

Chakraborty et al. studied the role of placenta on the growth of different bacteria. They found that placenta prevents the growth of clinically isolated bacteria, such as E. coli, from urine and blood culture. They found placenta to also have an inhibitory role in the growth of bacteria (such as E. coli, Staphylococcus aureus) and fungi (such as Saccharomyces cerevisae, Kluyvero-myces fragilis, and Candida albicans).


Improves Mental and Intellectual Development


Grebennikova et al. analyzed the effect of transplantation of human fetal tissue on children with Down syndrome. The children underwent neuro-psychological testing before treatment, six months after the first transplantation, and six months after the second transplantation. They found a significant increase in mental development after six months of the first transplant, and a further increase after the second transplantation. They also noted an improvement in perception and control. Placenta extract has also been shown to aid in the treatment of Gaucher's disease, strengthens the kidneys and prevents post natal depression.


Inhibits Viral Growth


The factors controlling HIV-1 transmission from mother to infant are not clearly understood. Studies in the past have suggested the existence of maternal and placental-protective mechanisms that inhibit viral replication in utero. Sharma et al. explored the role of placenta on the HIV-1 virus. Their studies demonstrated that a derivative of human placental stromal cells protected HIV-1 infected cells from virus-induced apoptosis and suppressed virus production.


Increases Neutrophils


Neutrophils are the most common type of white blood cell, comprising about 50-70% of all white blood cells. They are phagocytic, meaning that they can ingest other cells (though they do not survive the act). Neutrophils are the first immune cells to arrive at a site of infection, through a process known as chemotaxis.

Neutrophils are short-lived, with a half-life of four-to-ten hours when not activated. They experience immediate death upon ingesting a pathogen, but they are plentiful and responsible for the bulk of an immune response. They are the main component of pus and are responsible for its whitish color. Neutrophils are present in the bloodstream until signaled to a site of infection by chemical cues in the body. They are fast-acting, arriving at the site of infection within an hour.

Back to Top